Modern view on the prevention of obstetric and perinatal complications in pregnant women with allogeneic fetus




assisted reproductive technologies, in-vitro fertilization, allogenous fetus, immune tolerance, oocyte donation, surrogacy, obstetric complications, perinatal outcomes, fetoplacental complex psychological status


The widespread use of assisted reproductive technologies is owed to the rapid development of biomedical science. However, progress is accompanied by a steady decline in the reproductive health of the population, so the lack of knowledge today on theoretical and practical aspects remains significant. Despite the improvement of donor oocyte manipulation techniques and the outstanding success in obstetric and perinatal outcomes in cases of pregnancies with fully allogeneic fetus, the actual data on the incidence of complications of pregnancy, childbirth and postpartum period in this category of patients remain unclear.

Purpose - to analyze the results of obstetric and perinatal complications in pregnant women with allogeneic fetuses, and factors that may affect them.

This article summarizes the current data on obstetric and perinatal complications in pregnant women with allogeneic fetus, analyzes the biological preconditions for their occurrence, features of the fetoplacental complex in such patients, as well as the psychological status of pregnant women with allogeneic fetus, it’s potential impact on pregnancy, childbirth and the postpartum period.

No conflict of interests was declared by the authors.


ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. (2018). Obstetrics and gynecology. 132 (1): e44-e52.; PMid:29939940

Adams DH, Clark RA, Davies MJ et al. (2016). A meta-analysis of neonatal health outcomes from oocyte donation. Journal of developmental origins of health and disease. 7 (3): 257-272.; PMid:26611736

Applegarth L, Goldberg NC, Cholst I et al. (1995). Families created through ovum donation: a preliminary investigation of obstetrical outcome and psychosocial adjustment. Journal of assisted reproduction and genetics. 12 (9): 574-580.; PMid:8580652

Bartlett JA. (1991). Psychiatric issues in non-anonymous oocyte donation. Motivations and expectations of women donors and recipients. Psychosomatics. 32 (4): 433-437.

Berntsen S, Larsen EC, la Cour Freiesleben N et al. (2021). Pregnancy outcomes following oocyte donation. Best practice & research. Clinical obstetrics & gynaecology. 70: 81-91.; PMid:32741624

Berntsen S, Söderström-Anttila V, Wennerholm UB et al. (2019). The health of children conceived by ART: 'the chicken or the egg?'. Human reproduction update. 25 (2): 137-158.; PMid:30753453

Blázquez A, García D, Rodríguez A et al. (2016). Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis. Journal of assisted reproduction and genetics. 33 (7): 855-863.; PMid:27007875 PMCid:PMC4930777

Bracewell-Milnes T, Saso S, Bora S et al. (2016). Investigating psychosocial attitudes, motivations and experiences of oocyte donors, recipients and egg sharers: a systematic review. Human reproduction update. 22 (4): 450-465.; PMid:27016289

Brady P, Brison N, Van Den Bogaert K et al. (2016). Clinical implementation of NIPT - technical and biological challenges. Clinical genetics. 89 (5): 523-530.; PMid:25867715

Carolan M. (2003). Late motherhood: the experience of parturition for first time mothers aged over 35 years. Australian journal of midwifery: professional journal of the Australian College of Midwives Incorporated. 16 (2): 17-20.

Casale M, Carlqvist A. (2021). Is social support related to better mental health, treatment continuation and success rates among individuals undergoing in-vitro fertilization? Systematic review and meta-analysis protocol. PloS one. 16 (6): e0252492.; PMid:34061903 PMCid:PMC8168841

Chervenak FA, McCullough LB. (2021). Ethics and Professionalism Guidelines for Obstetrics and Gynecology. London: International Federation of Gynecology and Obstetrics: 289.

Clua E, Meler E, Rodríguez D et al. (2016). Obstetric and perinatal complications in an oocyte donation programme. Is it time to limit the number of embryos to transfer?. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 32 (4): 267-271.; PMid:26490075

Coughlan C, Ledger W, Wang Q et al. (2014). Recurrent implantation failure: definition and management. Reproductive biomedicine online. 28 (1): 14-38.; PMid:24269084

Dar S, Lazer T, Swanson S et al. (2015). Assisted reproduction involving gestational surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program. Human reproduction (Oxford, England). 30 (2): 345-352.; PMid:25518975

De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, Scaravelli G, Smeenk J, Vidakovic S, Goossens V & European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). (2020). ART in Europe, 2015: results generated from European registries by ESHRE. Human reproduction open. 1: hoz038.; PMid:32123753 PMCid:PMC7038942

Edelmann RJ, Connolly KJ. (2000). Gender differences in response to infertility and infertility investigations: Real or illusory. British Journal of Health Psychology. 5 (4): 365-375.

Eichelberger KY. (2019). The association between assisted reproduction technology (ART) and abnormal placentation. BJOG. 126 (2): 219.; PMid:29900643

Elenis E, Sydsjö G, Skalkidou A et al. (2016). Neonatal outcomes in pregnancies resulting from oocyte donation: a cohort study in Sweden. BMC pediatrics. 16 (1): 170.; PMid:27769207 PMCid:PMC5073900

Frederiksen Y, Farver-Vestergaard I, Skovgård NG et al. (2015). Efficacy of psychosocial interventions for psychological and pregnancy outcomes in infertile women and men: a systematic review and meta-analysis. BMJ open. 5 (1): e006592.; PMid:25631310 PMCid:PMC4316425

Gameiro S, Boivin J, Dancet E et al. (2015). ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction - a guide for fertility staff. Human reproduction (Oxford, England). 30 (11): 2476-2485.; PMid:26345684

Geisler M, Meaney S, Waterstone J et al. (2020). Stress and the impact on the outcome of medically assisted reproduction. European journal of obstetrics, gynecology, and reproductive biology. 248: 187-192.; PMid:32240891

Greenfeld DA. (1997). Does psychological support and counseling reduce the stress experienced by couples involved in assisted reproductive technology? Journal of assisted reproduction and genetics. 14 (4): 186-188.; PMid:9130064 PMCid:PMC3454690

Hammarberg K, Fisher JRW, Wynter K. (2008). Psychological and social aspects of pregnancy, childbirth and early parenting after assisted conception: a systematic review. Hum. Reprod. Update. 14 (5): 395-414.; PMid:18653674

Hiby SE, Regan L, Lo W et al. (2008). Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Human reproduction (Oxford, England). 23 (4): 972-976.; PMid:18263639

Hiby SE, Walker JJ, O'shaughnessy KM et al. (2004). Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. The Journal of experimental medicine. 200 (8): 957-965.; PMid:15477349 PMCid:PMC2211839

Johnsen GM, Størvold GL, Drabbels J et al. (2018). The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia. Journal of reproductive immunology. 129: 23-29.; PMid:30055414

Jones BP, Ranaei-Zamani N, Vali S et al. (2021). Options for acquiring motherhood in absolute uterine factor infertility; adoption, surrogacy and uterine transplantation. The obstetrician & gynaecologist: the journal for continuing professional development from the Royal College of Obstetricians & Gynaecologists. 23 (2): 138-147.; PMid:34248417 PMCid:PMC8252631

Klock SC, Covington SN. (2015). Results of the Minnesota Multiphasic Personality Inventory-2 among gestational surrogacy candidates. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 130 (3): 257-260.; PMid:25980365

Krieg SA, Henne MB, Westphal LM. (2008). Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertility and sterility. 90 (1): 65-70.; PMid:17727845

Lashley LE, Haasnoot GW, Spruyt-Gerritse M et al. (2015). Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnancies. Journal of reproductive immunology. 112: 29-33.; PMid:26232147

Luke B, Brown MB, Wantman E et al. (2019). Risk of severe maternal morbidity by maternal fertility status: a US study in 8 states. American journal of obstetrics and gynecology. 220 (2): 195.e1-195.e12.; PMid:30321527

Mascarenhas M, Sunkara SK, Antonisamy B et al. (2017). Higher risk of preterm birth and low birth weight following oocyte donation: A systematic review and meta-analysis. European journal of obstetrics, gynecology, and reproductive biology. 218: 60-67.; PMid:28942045

Massarotti C, Gentile G, Ferreccio C et al. (2019). Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 35 (6): 485-489.; PMid:30612477

Meldrum DR. (2016). Lightening the burden of care in assisted reproductive technology. Fertil Steril. 105 (5): 1144-1145.; PMid:26989047

Melnick AP, Rosenwaks Z. (2018). Oocyte donation: insights gleaned and future challenges. Fertility and sterility. 110 (6): 988-993.; PMid:30396566

Modest AM, Johnson KM, Karumanchi SA et al. (2019). Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study. Journal of assisted reproduction and genetics. 36 (9): 1917-1926.; PMid:31359234 PMCid:PMC6730979

Monga M, Alexandrescu B, Katz SE et al. (2004). Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 63 (1): 126-130.; PMid:14751363

Moreno-Sepulveda J, Checa MA. (2019). Risk of adverse perinatal outcomes after oocyte donation: a systematic review and meta-analysis. Journal of assisted reproduction and genetics. 36 (10): 2017-2037.; PMid:31440959 PMCid:PMC6823473

Nejdet S, Bergh C, Källén K et al. (2016). High risks of maternal and perinatal complications in singletons born after oocyte donation. Acta obstetricia et gynecologica Scandinavica. 95 (8): 879-886.; PMid:27060438

Nilsson LL, Djurisic S, Hviid TV. (2014). Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction. Frontiers in immunology. 5: 198.; PMid:24860568 PMCid:PMC4026753

Osaikhuwuomwan JA, Aziken ME. (2021). Pregnancy in Older Women: Analysis of Outcomes in Pregnancies from Donor oocyte In- vitro Fertilization. Journal of human reproductive sciences. 14 (3): 300-306.; PMid:34759621 PMCid:PMC8527082

Papúchová H, Meissner TB, Li Q et al. (2019). The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface. Frontiers in immunology. 10: 2730.; PMid:31921098 PMCid:PMC6913657

Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology. (2021). Guidance regarding gamete and embryo donation. Fertility and sterility. 115 (6): 1395-1410.; PMid:33838871

Qin J, Liu X, Sheng X et al. (2016). Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertility and sterility. 105 (1): 73-85.e856.; PMid:26453266

Rizzello F, Coccia ME, Fatini C et al. (2020). Comorbidities, risk factors and maternal/perinatal outcomes in oocyte donation pregnancies. Reproductive biomedicine online. 41 (2): 309-315.; PMid:32576492

Rodriguez-Wallberg KA, Berger AS, Fagerberg A et al. (2019). Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 35 (4): 314-319.; PMid:30626251

Rouas-Freiss N, Moreau P, LeMaoult J et al. (2021). Role of the HLA-G immune checkpoint molecule in pregnancy. Human Immunology. 82 (5): 353-361.; PMid:33745758

San Lazaro Campillo I, Meaney S, Corcoran P et al. (2019). Risk factors for miscarriage among women attending an early pregnancy assessment unit (EPAU): a prospective cohort study. Irish journal of medical science. 188 (3): 903-912.; PMid:30607825

Shah A, Parisaei M, Garner J. (2019). Obstetric Complications of Donor Egg Conception Pregnancies. Journal of obstetrics and gynaecology of India. 69 (5): 395-398.; PMid:31598040 PMCid:PMC6765033

Simopoulou M, Sfakianoudis K, Tsioulou P et al. (2018). Risks in Surrogacy Considering the Embryo: From the Preimplantation to the Gestational and Neonatal Period. BioMed research international: 6287507.; PMid:30112409 PMCid:PMC6077588

Smith NK, Madeira J, Millard HR. (2015). Sexual function and fertility quality of life in women using in vitro fertilization. The journal of sexual medicine. 12 (4): 985-993.; PMid:25639162

Söderström-Anttila V, Wennerholm UB, Loft A et al. (2016). Surrogacy: outcomes for surrogate mothers, children and the resulting families-a systematic review. Human reproduction update. 22 (2): 260-276.; PMid:26454266

Tan CY, Ho JF, Chong YS et al. (2008). Paternal contribution of HLA-G*0106 significantly increases risk for preeclampsia in multigravid pregnancies. Mol Hum Reprod. 14 (5): 317-324.; PMid:18353802

Tilburgs T, Scherjon SA, van der Mast BJ et al. (2009). Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. Journal of Reproductive Immunology. 82 (2): 148-157.; PMid:19631389

Van Bentem K, Lashley E, Bos M et al. (2019). Relating the number of human leucocytes antigen mismatches to pregnancy complications in oocyte donation pregnancies: study protocol for a prospective multicentre cohort study (DONOR study). BMJ open. 9 (7): e027469.; PMid:31345965 PMCid:PMC6661658

Vercammen MJ, Verloes A, Van de Velde H et al. (2008). Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Human reproduction update. 14 (3): 209-218.; PMid:18390888

Vermey BG, Buchanan A, Chambers GM et al. (2019). Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. BJOG: an international journal of obstetrics and gynaecology. 126 (2): 209-218.; PMid:29740927

Wedenoja S, Yoshihara M, Teder H et al. (2020). Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia. EbioMedicine. 59: 102872.; PMid:32680723 PMCid:PMC7502669

Wilczyński JR. (2006). Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism? Human immunology. 67 (7): 492-511.; PMid:16829304

Woo I, Hindoyan R, Landay M et al. (2017). Perinatal outcomes after natural conception versus in vitro fertilization (IVF) in gestational surrogates: a model to evaluate IVF treatment versus maternal effects. Fertility and sterility. 108 (6): 993-998.; PMid:29202976

Yadav V, Bakolia P, Malhotra N et al. (2018). Comparison of Obstetric Outcomes of Pregnancies after Donor-Oocyte In vitro Fertilization and Self-Oocyte In vitro Fertilization: A Retrospective Cohort Study. Journal of human reproductive sciences. 11 (4): 370-375.; PMid:30787523 PMCid:PMC6333036

Yang X, Yang Y, Yuan Y et al. (2020). The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review. BioMed research international. 2020: 4808072.; PMid:32309433 PMCid:PMC7149372